[1] Hansson GK, Hermansson A. The immune system in
atherosclerosis[J]. Nat Immunol, 2011, 12(3):204-212.
[2] Oishi Y, Hayashi S, Isagawa T, et al. Bmal1 regulates
inflammatory responses in macrophages by modulating
enhancer RNA transcription[J]. Sci Rep, 2017, 7(1):7086.
[3] Zhu YH, Xian XM, Wang ZZ, et al. Research progress on the relationship between atherosclerosis and inflammation[J].
Biomolecules, 2018, 8(3):80.
[4] Gwon DH, Lee WY, Shin N, et al. BMAL1 suppresses
proliferation, migration, and invasion of U87MG cells
by downregulating cyclin B1, phospho-AKT, and
metalloproteinase-9[J]. Int J Mol Sci, 2020, 21(7):2352.
[5] Reppert SM, Weaver DR. Molecular analysis of mammalian
circadian rhythms[J]. Annu Rev Physiol, 2001, 63:647-676.
[6] Yang GR, Zhang JY, Jiang TT, et al. Bmal1 deletion in
myeloid cells attenuates atherosclerotic lesion development
and restrains abdominal aortic aneurysm formation in
hyperlipidemic mice[J]. Arterioscler Thromb Vasc Biol, 2020,
40(6):1523-1532.
[7] Rabinovich-Nikitin I, Lieberman B, Martino TA, et al.
Circadian-regulated cell death in cardiovascular diseases[J].
Circulation, 2019, 139(7):965-980.
[8] Brown BA, Williams H, George SJ. Evidence for the
involvement of matrix-degrading metalloproteinases (MMPs)
in atherosclerosis[J]. Prog Mol Biol Transl Sci, 2017, 147:
197-237.
[9] Linton MF, Babaev VR, Huang JS, et al. Macrophage
apoptosis and efferocytosis in the pathogenesis of
atherosclerosis[J]. Circ J, 2016, 80(11):2259-2268.
[10] Takaguri A, Sasano J, Akihiro O, et al. The role of circadian
clock gene BMAL1 in vascular proliferation[J]. Eur J
Pharmacol, 2020, 872:172924.
[11] Pan XY, Bradfield CA, Hussain MM. Global and hepatocytespecific
ablation of Bmal1 induces hyperlipidaemia and
enhances atherosclerosis[J]. Nat Commun, 2016, 7:13011.
[12] Fiotti N, Altamura N, Orlando C, et al. Metalloproteinases-2, -9
and TIMP-1 expression in stable and unstable coronary
plaques undergoing PCI[J]. Int J Cardiol, 2008, 127(3):350-
357.
[13] Anea CB, Ali MI, Osmond JM, et al. Matrix metalloproteinase 2
and 9 dysfunction underlie vascular stiffness in circadian
clock mutant mice[J]. Arterioscler Thromb Vasc Biol, 2010,
30(12):2535-2543.